Baxter International Earns Record Profits with $3.65B in Revenues
April 28, 2023
Trending News ☀️
Revenues were also higher than expected, reaching $3.65 billion, beating analyst predictions by $50 million. The company operates in four key areas; Clinical Nutrition, Medication Delivery, Renal, and Pharmaceuticals. Baxter ($NYSE:BAX)’s products range from medical devices, to infusion systems, and nutrition products. In addition to providing these medical products and services, the company also provides end-to-end solutions such as software, analytics, and support services to healthcare providers.
Baxter is committed to improving patient care and safety through innovation and dedicated customer service. The company has invested heavily in new technologies and facilities to ensure that its products meet the highest standards of regulatory compliance and quality.
Price History
On Thursday, the company’s stock opened at $47.0 and closed at $46.8, up by 1.6% from its last closing price of 46.1. The profits have been attributed to the company’s commitment to focusing on medical products and technologies that ensure patient safety and well-being. Baxter has invested heavily in research and development and has acquired a number of companies that have helped it expand its product portfolio and gain access to new markets. In addition to its strong performance in the medical sector, Baxter has also seen success in its other business units, including pharmaceuticals and diagnostics.
This has enabled the company to become a leader in providing healthcare solutions across multiple industries. Going forward, Baxter International is well-positioned to further capitalize on its record profits and continue to deliver innovative products and services to its customers. With an increasing focus on patient safety and well-being, the company is well-positioned to maintain its market presence and capitalize on its recent success. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Baxter International. More…
| Total Revenues | Net Income | Net Margin |
| 15.11k | -2.43k | -4.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Baxter International. More…
| Operations | Investing | Financing |
| 1.21k | -931 | -1.44k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Baxter International. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 28.29k | 22.39k | 10.98 |
Key Ratios Snapshot
Some of the financial key ratios for Baxter International are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 10.0% | 2.0% | -12.8% |
| FCF Margin | ROE | ROA |
| 3.5% | -21.3% | -4.3% |
Analysis
GoodWhale has conducted an analysis of BAXTER INTERNATIONAL‘s fundamentals, and our initial findings suggest that the company is high risk in terms of financial and business aspects. After performing detailed analysis of the company’s balance sheet, cashflow statement, and other non-financial aspects, we identified three risk warnings that investors should be aware of. To access more detail on these risks and our analysis in full, please register on goodwhale.com. More…
Peers
Baxter International Inc is a large medical device company. Its main competitors are Utah Medical Products Inc, Clarity Medical Group Holding Ltd, and Merit Medical Systems Inc.
– Utah Medical Products Inc ($NASDAQ:UTMD)
The company’s market cap is $313.74 million and its ROE is 11.43%. Utah Medical Products, Inc. engages in the design, manufacture, and marketing of medical devices. It operates through the following segments: Pregnancy & Newborn, Patient Care, and Animal Health. The Pregnancy & Newborn segment offers a line of products used by obstetricians, gynecologists, and neonatal caregivers for the health and well-being of pregnant women and their babies. The Patient Care segment provides a line of products used by hospitals, clinics, and home healthcare providers for the treatment of respiratory and other conditions. The Animal Health segment offers a line of products used by veterinarians for the health and well-being of animals.
– Clarity Medical Group Holding Ltd ($SEHK:01406)
According to Clarity Medical Group Holding Ltd’s market cap as of 2022, the company is worth 599.47 million. Clarity Medical Group Holding Ltd is a Medical Group that provides healthcare services. The company was founded in 2014 and is headquartered in Hong Kong.
– Merit Medical Systems Inc ($NASDAQ:MMSI)
Medstronic is a medical device company that manufactures and sells a variety of medical devices and equipment. The company has a market cap of 3.29B as of 2022 and a ROE of 5.86%. Medtronic’s products are used in a variety of medical procedures, including cardiac surgery, vascular surgery, and neurology.
Summary
Baxter International released its quarterly earnings report, beating both earnings-per-share (EPS) and revenue estimates. Investors are likely to view the results positively as Baxter continues to perform well despite the challenging market conditions. The company’s stock price is expected to increase in the short term.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
